COMMUNIQUÉS West-GlobeNewswire

Priority Partners Opening Two More Free Mini-Pantries in Maryland
10/12/2025
New Cupboards Target Food Insecurity In Time for Holidays HANOVER, Md., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Priority Partners’ Cupboards Project is celebrating the season of giving with the launch of two new free self- [...]
EmblemHealth Announces New Agreement with the Hospital for Special Surgery
10/12/2025
City workers will retain access to the country’s highest-ranked orthopedic center NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- With the New York City Employees (NYCE) PPO health plan going live January 1, EmblemHealth [...]
Une utilisation précoce de CARVYKTI®▼ (ciltacabtagène autoleucel) a permis d’obtenir des rémissions durables sans traitement pendant 2,5 ans chez des patients atteints d’un myélome multiple en rechute ou réfractaire
10/12/2025
Les données de suivi issues de l’étude CARTITUDE-4 révèlent qu’au moins 80 pour cent des patients à risque standard traités n’ont présenté aucune progression de la maladie et n’ont reçu aucun traitement après une [...]
Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants
10/12/2025
IXCHIQ ® a été bien toléré par les enfants âgés d’un à onze ans indépendamment de la dose de vaccin reçue ou d’une précédente infection au virus du chikungunya Les niveaux d’anticorps demeurent élevés après douze mois [...]
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
10/12/2025
IXCHIQ ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after twelve months in both dose groups, although more [...]
Tristan Imbert coopté Administrateur Indépendant
10/12/2025
Communiqué de presse Paris - Le 10 décembre 2025 - EUROAPI annonce aujourd’hui qu’à la suite de la démission de Rodolfo Savitzky de son poste d’Administrateur Indépendant (effective au 31 décembre 2025) 1 et sur [...]
Tristan Imbert co-opted as Independent Director
10/12/2025
Press Release Paris – December 10, 2025 - EUROAPI today announces that, following the resignation of Rodolfo Savitzky from his position as Independent Director (effective December 31, 2025) 1 , and upon the [...]
GENFIT : GNS561 montre une activité antitumorale prometteuse en combinaison thérapeutique
10/12/2025
Données préliminaires très encourageantes de l’étude de Phase 1b en cours évaluant le médicament expérimental GNS561 associé à un inhibiteur de MEK (MEKi) dans le cholangiocarcinome (CCA) avec mutation KRAS, [...]
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
10/12/2025
Highly encouraging early data from the ongoing Phase 1b study evaluating investigational drug GNS561 with a MEK inhibitor (MEKi) in KRAS mutated cholangiocarcinoma (CCA), positioning this novel combination as a [...]
EssilorLuxottica va collaborer avec la fondation Chips-IT pour accélérer dans les lunettes connectées
10/12/2025
EssilorLuxottica va collaborer avec la fondation Chips-IT pour accélérer dans les lunettes connectées Paris, France (10 décembre 2025) – EssilorLuxottica a annoncé aujourd'hui une collaboration avec la fondation Chips- [...]
EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear
10/12/2025
EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear Paris, France (10 December 2025) – EssilorLuxottica announces it is joining forces with Fondazione Chips-IT, Italy’s [...]
Persephone Biosciences Announces Publication in Cell Host & Microbe Highlighting the Critical Need to Restore Bifidobacterium in the Infant Gut Microbiome
10/12/2025
- Evidence shows infant microbiome trajectories established in the first months of life persist, shaping immune function and allergy risk into childhood - - Targeted early-life probiotic interventions using B. infantis [...]
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
10/12/2025
SAN MATEO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
10/12/2025
WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve ® Antimicrobial Wound Gel Spray [...]
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
10/12/2025
Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque ProMIS on track to complete enrollment in PRECISE-AD trial in Alzheimer’s disease [...]
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
10/12/2025
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case exceeding objective [...]
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
10/12/2025
BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS ® ) Phase 3 study of Bria-IMT™ plus immune check point inhibitor (CPI) continues to support biomarkers to [...]
Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America
10/12/2025
ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships , a global initiative designed to [...]
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
10/12/2025
CAMBRIDGE, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]

Pages